Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no other changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange Detected- The page revision was updated from v3.4.0 to v3.4.1 (added v3.4.1 and removed v3.4.0).SummaryDifference0.1%

- Check33 days agoChange DetectedUI updates include adding Show glossary and Hide glossary controls, and introducing new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' in Study Record Dates, while removing older labels like 'Last Update Submitted that met QC Criteria' and 'Last Update Posted (Estimated)'. Footer/meta updates include adding 'No FEAR Act Data' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 at the bottom of the page.SummaryDifference0.0%

- Check69 days agoChange DetectedStudy status updated to Completed with an actual completion date of 2025-10-27, replacing the previous Active, not recruiting status. A list of trial locations across multiple US sites was added.SummaryDifference2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the page footer, with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.